skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Products

Show More

Show More

100+ Total results for product and free and sample content found

Biomedtracker, Datamonitor Healthcare

COVID-19 24 hour webinar recordings

31 Aug 2022

Catch up on any missed COVID-19 24 hour webinar sessions

Topic Cardiovascular Coronavirus

Pharma Intelligence Apps

UK Adults Call on Pharma Companies to Keep Improving COVID-19 Treatments Without Sidelining Other Conditions

06 Jan 2022

UK Adults Call on Pharma Companies to Keep Improving COVID-19 Treatments Without Sidelining Other Conditions

London, 04.01.22 – Pharmaceutical companies must keep improving COVID-19 treatments in line with new variants without sidelining work in other areas of health, according to new data from YouGov and Informa Pharma Intelligence, the world’s leading intelligence provider for the biopharma industry.

Topic Coronavirus

Pharma Intelligence Apps

Americans Push for Rapid Pharma Innovation: Over a Quarter Believe a Better COVID-19 Vaccine Will Be Available in the Near Future

17 Dec 2021

Americans Push for Rapid Pharma Innovation: Over a Quarter Believe a Better COVID-19 Vaccine Will Be Available in the Near Future

New report from Informa Pharma Intelligence finds Americans are closely watching COVID-19 vaccine and treatment clinical trials as the U.S. continues to encounter new variants

Topic Coronavirus

Citeline, Trialtrove

2020 Clinical Trials Roundup: Disruptions to the Trial Landscape

03 Nov 2021

2020 Clinical Trials Roundup: Disruptions to the Trial Landscape

Our annual analysis dissects the data of all Phase I–III clinical trials that started in a year dominated by COVID-19.

Topic Coronavirus

Biomedtracker, Datamonitor Healthcare

2020 Deal-Making Roundup

21 Sep 2021

2020 Deal-Making Roundup

Against a backdrop of unprecedented disruption, the biopharma and medtech industries reached incredible heights for deal-making activity during 2020.

Topic Drug Review Coronavirus

While Over Three-Quarters of Americans Are Willing to Take at Least One of the Authorized COVID-19 Vaccines, Nearly a Quarter Are Still Hesitant as the U.S. Changes Course on Mitigation Strategy

03 Jun 2021

While Over Three-Quarters of Americans Are Willing to Take at Least One of the Authorized COVID-19 Vaccines, Nearly a Quarter Are Still Hesitant as the U.S. Changes Course on Mitigation Strategy

New Informa Pharma Intelligence report shows that while vaccine hesitancy creates an uphill battle for herd immunity, virus manageability may be possible as the U.S. marches toward July 4 deadline of 70% of American adults partially vaccinated.  

Topic Coronavirus Clinical Trials

Q2 2021 Clinical Trials and the COVID-19 Vaccine Pulse Report

By Karen Currie 03 Jun 2021

pulse-2021

The goal of our second Clinical Trials & the COVID-19 Vaccine Pulse Report is to uncover who is still hesitant to take a vaccine, and what public health experts from pharma to the U.S. government can do to turn the tide.

Topic Coronavirus Clinical Trials

Trialtrove

2020 Completed Trials A Bumpy Road for Industry Sponsored Clinical Studies

20 May 2021

Completed Trials 2020 Whitepaper

Over the past five years, our analysis of completed trials consistently observed growth trends.

Topic Coronavirus Clinical Trials

Clinical Trial Webinar Series

16 Apr 2021

Clinical Trial Webinar Series

Learn about the latest trends affecting biopharma R&D including, study diversity & transparency, predictive feasibility and more...

Topic Coronavirus Clinical Trials BioPharmaceutical

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.

Contact us for product technical and account support.

  • US Toll-Free   : +1 888 670 8900 
  • US Toll             : +1 212-600-3520
  • UK & Europe : +44 (0) 208 052 0700

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: